Pre-referral artesunate in severe malaria

The Lancet

Volumn 373, Issue 9677, 2009, Pages 1762-1763

  Bello, Shaibu Oricha ^a  

^a USMANU DANFODIYO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; ARTEMETHER; ARTESUNATE;

COMATOSE PATIENT; CONVULSION; ENVIRONMENTAL FACTOR; HUMAN; LETTER; MALARIA; MEDICAL ETHICS; NONHUMAN; PRIORITY JOURNAL;

EID: 65649083422     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60980-6     Document Type: Letter

References (5)

1. Gomes M.F., Faiz M.A., Gyapong J.O., et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet 373 (2009) 557-566
2. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41 (1997) 1413-1422
3. Krishna S., Planche T., Agbenyega T., et al. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother 45 (2001) 509-516
4. Brewer T.G., Peggins J.O., Grate S.J., et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 88 suppl 1 (1994) S33-S36
5. Nontprasert A., Pukrittayakamee S., Prakongpan S., Supanaranond W., Looareesuwan S., and White N.J. Assessment of the neurotoxicity of oral dihydroartemisinin in mice. Trans R Soc Trop Med Hyg 96 (2002) 99-101